Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
FDA Office of Orphan Products Development Children's Hospital and Health Center |
---|---|
Information provided by: | FDA Office of Orphan Products Development |
ClinicalTrials.gov Identifier: | NCT00004828 |
OBJECTIVES: I. Determine the pharmacokinetics of exogenous liothyronine administered in children undergoing the modified Fontan procedure.
II. Determine the liothyronine supplementation dose that counters the fall in serum liothyronine concentrations and provides the greatest potential myocardial benefit after the modified Fontan procedure. III. Evaluate the potential toxicity of exogenous liothyronine administered in children undergoing a modified Fontan procedure.
Condition | Intervention | Phase |
---|---|---|
Tricuspid Atresia Heart Defects, Congenital |
Drug: liothyronine I 131 |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Placebo Control |
Estimated Enrollment: | 28 |
Study Start Date: | December 1994 |
Estimated Study Completion Date: | December 1997 |
PROTOCOL OUTLINE: This is a randomized, placebo controlled, dose escalation study.
Initially, patients are randomized to receive either 1 of 3 different dosages of liothyronine or placebo after undergoing the Fontan procedure.
If no unacceptable toxicity is observed in this group, a third dose level of liothyronine is added to the randomization. A total of 7 patients are enrolled at each dose level. All randomized study drugs are administered by continuous infusion over 1 hour after surgery.
Cardiac function is assessed 5 days after surgery.
Ages Eligible for Study: | up to 17 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Study ID Numbers: | 199/13357, CHSD-585, CHSD-FDR001195 |
Study First Received: | February 24, 2000 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00004828 History of Changes |
Health Authority: | United States: Federal Government |
cardiovascular and respiratory diseases heart defects rare disease |
Single Ventricular Heart Heart Diseases Tricuspid Atresia Cardiovascular Abnormalities Respiration Disorders |
Rare Diseases Congenital Abnormalities Heart Defects, Congenital Heart Valve Diseases |
Heart Diseases Tricuspid Atresia Cardiovascular Abnormalities Cardiovascular Diseases |
Congenital Abnormalities Heart Defects, Congenital Heart Valve Diseases |